Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginTimes Interest Earned

Cellectis (CLLS) Equity Average (2016 - 2025)

Cellectis (CLLS) has 7 years of Equity Average data on record, last reported at $169.6 million in Q4 2022.

  • For Q4 2022, Equity Average fell 32.83% year-over-year to $169.6 million; the TTM value through Dec 2022 reached $169.6 million, down 32.83%, while the annual FY2022 figure was $169.6 million, 32.83% down from the prior year.
  • Equity Average reached $169.6 million in Q4 2022 per CLLS's latest filing, down from $252.5 million in the prior quarter.
  • Across five years, Equity Average topped out at $346.6 million in Q4 2018 and bottomed at $169.6 million in Q4 2022.
  • Average Equity Average over 4 years is $278.8 million, with a median of $299.5 million recorded in 2020.
  • Peak YoY movement for Equity Average: rose 24.52% in 2018, then tumbled 32.83% in 2022.
  • A 4-year view of Equity Average shows it stood at $346.6 million in 2018, then dropped by 0.03% to $346.5 million in 2020, then fell by 27.13% to $252.5 million in 2021, then crashed by 32.83% to $169.6 million in 2022.
  • Per Business Quant database, its latest 3 readings for Equity Average were $169.6 million in Q4 2022, $252.5 million in Q4 2021, and $346.5 million in Q4 2020.